Dyspepsia differential diagnosis
Click here to return to main page: Dyspepsia
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahad Hasan, M.D.[2] Ajay Gade MD[3]]
Overview
Dyspepsia must be differentiated from other organic and functional disorders that present with epigastric pain or discomfort. Per the American College of Gastroenterology/Canadian Association of Gastroenterology (ACG/CAG) 2017 guideline and the British Society of Gastroenterology (BSG) 2022 guideline on functional dyspepsia, dyspepsia is first classified as uninvestigated dyspepsia (symptoms without prior endoscopic evaluation), organic (structural) dyspepsia, and functional dyspepsia (Rome IV criteria, in the absence of a structural, metabolic, or systemic explanation for symptoms after endoscopic evaluation).[1][2][3]
Organic causes that mimic dyspepsia and must be excluded include peptic ulcer disease, gastritis, gastroesophageal reflux disease, gastric adenocarcinoma, gastric lymphoma, acute pancreatitis, chronic pancreatitis, biliary colic/cholelithiasis, gastroparesis, gastric outlet obstruction, celiac disease, drug/medication-induced dyspepsia (e.g., NSAIDs, bisphosphonates, iron, potassium salts), and, less commonly, acute appendicitis, pleural empyema, and myocardial infarction, all of which can present with epigastric pain.[4][5] Age ≥60 years or the presence of alarm features (unintentional weight loss, progressive dysphagia, odynophagia, unexplained iron-deficiency anemia, persistent vomiting, a palpable mass or lymphadenopathy, family history of upper GI cancer, or GI bleeding) should prompt prompt upper endoscopy to exclude malignancy or other significant structural disease.[1]
Differentiating Dyspepsia from other Diseases
Dyspepsia must be differentiated from other diseases that present with epigastric pain, such as gastritis, gastroesophageal reflux disease, acute pancreatitis, chronic pancreatitis, biliary colic/cholelithiasis, gastric outlet obstruction, myocardial infarction, pleural empyema, and acute appendicitis.[4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21]
Diagnostic Approach Based on Current Guidelines
The ACG/CAG 2017 guideline and the BSG 2022 guideline recommend a two-tier, age- and alarm-feature-based approach to distinguish dyspepsia from other diseases before a label of functional dyspepsia is applied.[1][2] Patients younger than 60 years without alarm features should undergo non-invasive testing for H. pylori (13C-urea breath test or stool antigen test, both preferred over serology) and treatment if positive (test-and-treat strategy, strong recommendation, high-quality evidence); alarm features alone should not automatically trigger endoscopy in this age group but should be assessed on a case-by-case basis.[1] Patients aged 60 years or older, or of any age with alarm features, should undergo upper endoscopy to exclude upper GI neoplasia and other structural disease (conditional recommendation for age alone).[1]
An updated systematic review and meta-analysis of endoscopic findings in dyspepsia (Ford AC, Moayyedi P, et al) found that more than 85% of upper endoscopies performed for dyspepsia are entirely normal; erosive esophagitis is the most common abnormality (pooled prevalence 11.0%, 95% CI 8.9–13.2%), followed by peptic ulcer (pooled prevalence 4.4%, 95% CI 2.5–6.7%), while gastroesophageal cancer is rare (<0.4%) and equally prevalent in dyspeptic and non-dyspeptic populations, supporting a conservative, alarm-feature/age-based approach to endoscopy rather than routine endoscopy in all comers.[2]
| Feature | Age <60 years, no alarm features | Age ≥60 years, or any alarm feature |
|---|---|---|
| Initial strategy | Non-invasive H. pylori test-and-treat (13C-urea breath test or stool antigen test) | Upper endoscopy to exclude malignancy/structural disease |
| Alarm features | Unintentional weight loss, GI bleeding/iron deficiency anemia, progressive dysphagia, persistent vomiting, palpable mass, family history of upper GI cancer | Same features mandate endoscopy regardless of age |
| If H. pylori negative and symptoms persist | Empiric proton pump inhibitor trial (4–8 weeks); if refractory, proceed to endoscopy | Not applicable (endoscopy already performed) |
| Diagnosis if endoscopy normal and no metabolic/structural cause found | Functional dyspepsia per Rome IV criteria (postprandial distress syndrome or epigastric pain syndrome, or overlap) | |
| Classification of pain in the abdomen based on etiology | Disease | Clinical manifestations | Diagnosis | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Signs | ||||||||||||||
| Fever | Rigors and chills | Abdominal Pain | Jaundice | GI Bleed | Hypo-
tension |
Guarding | Rebound Tenderness | Bowel sounds | Lab Findings | Imaging | |||||
| Abdominal causes | Inflammatory causes | Pancreato-biliary disorders | |||||||||||||
| Acute pancreatitis | + | − | Epigastric | ± | − | ± | − | − | N | Increased amylase / lipase | Ultrasound shows evidence of inflammation | ||||
| Chronic pancreatitis/pancreatic fibrosis | − | − | Epigastric, radiating to back | ± | − | − | − | − | N | Fecal elastase low; amylase/lipase may be normal | Endoscopic ultrasound with shear-wave elastography detects early parenchymal fibrosis missed on CT/MRI | ||||
| Biliary colic/dyskinesia | − | − | RUQ/Epigastric, may radiate to back or mimic chest pain | ± | − | − | − | − | N | Normal LFTs between episodes | Reduced gallbladder ejection fraction on cholecystokinin-HIDA scan (<38%) | ||||
| Cholelithiasis | ± | − | RUQ/Epigastric | ± | − | − | + | + | N to hyperactive for dislodged stone | Leukocytosis | Ultrasound shows gallstone | Murphy’s sign | |||
| Gastric/duodenal causes | Peptic ulcer disease | ± | − | EpisodicEpigastric | − |
|
+ in perforated | + | + | N | Air under diaphragm in upright CXR | ||||
| Gastritis | ± | − | Epigastric | + in chronic gastritis | − | H. pylori stool antigen or 13C-urea breath test preferred over serology | |||||||||
| Gastroesophageal reflux disease | − | − | Epigastric | − | − | − | − | − | Pooled prevalence of erosive esophagitis on endoscopy for dyspepsia ≈11.0% | ||||||
| Gastric outlet obstruction | − | − | Epigastric | − | − | ± | Hyperactive | ||||||||
| Celiac disease | − | − | Epigastric/diffuse, with bloating | − | − | − | − | − | Chronic diarrhea/steatorrhea | Anti-tissue transglutaminase IgA, total IgA | Duodenal biopsy: villous atrophy, scalloping of folds | ||||
| Intestinal causes | Acute appendicitis | + | +in pyogenic appendicitis | Starts in epigastrium, migrates to RLQ | − | − | + in perforated appendicitis | + | + | Hypoactive | Leukocytosis | Ultrasound shows evidence of inflammation | Nausea & vomiting, decreased appetite | ||
| Extra-abdominal causes | Pulmonary disorders | Pleural empyema | + | ± | RUQ/Epigastric | − | − | − | − | − | N | ||||
| Cardiovascular disorders | Myocardial Infarction | − | − | Epigastric | − | − | + in cardiogenic shock | − | − | N | Troponin elevated; electrocardiogram with ST changes | Regional wall motion abnormality on echocardiogram | |||
| Vascular disorders | Mesenteric ischemia (chronic) | − | − | Postprandial epigastric pain ("intestinal angina") | − | − | − | − | − | N | Weight loss, food fear | CT angiography/mesenteric duplex ultrasound shows stenosis of ≥2 splanchnic vessels | |||
| Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM=Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein | |||||||||||||||
| Disease | Cause | Symptoms | Diagnosis | Other findings | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pain | Nausea
& Vomiting |
Heartburn | Belching or
Bloating |
Weight loss | Loss of
Appetite |
Stools | Endoscopy findings | |||||
| Location | Aggravating Factors | Alleviating Factors | ||||||||||
| Acute gastritis |
|
Food | Antacids | ✔ | ✔ | ✔ | - | ✔ | Black stools | - | ||
| Chronic gastritis |
|
Food | Antacids | ✔ | ✔ | ✔ | ✔ | ✔ | - | H. pylori gastritis
Lymphocytic gastritis
|
- | |
| Atrophic gastritis | Epigastric pain | - | - | ✔ | - | ✔ | ✔ | - | H. pylori
|
Autoimmune gastritis diagnosis include:
| ||
| Crohn's disease | - | - | - | - | - | ✔ | ✔ |
|
|
|||
| GERD |
|
|
|
✔
(Suspect delayed gastric emptying) |
✔ | - | - | - | - |
|
Other symptoms:
Complications
| |
| Peptic ulcer disease |
|
|
|
|
✔ | ✔ | - | - | - | Gastric ulcers
Duodenal ulcers
|
Other diagnostic tests | |
| Gastrinoma |
|
- | - | ✔
(suspect gastric outlet obstruction) |
✔ | - | - | - | Useful in collecting the tissue for biopsy |
Diagnostic tests
| ||
| Gastric Adenocarcinoma |
|
- | - | ✔ | ✔ | ✔ | ✔ | ✔ |
|
Esophagogastroduodenoscopy
|
Other symptoms | |
| Primary gastric lymphoma |
|
- | - | - | - | - | ✔ | - | - | Useful in collecting the tissue for biopsy | Other symptoms
| |
Differentials of functional dyspepsia
Functional dyspepsia is diagnosed using Rome IV criteria and is subclassified into postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS), which may overlap.[3][22] Functional dyspepsia should be differentiated from other diseases that cause chronic nausea and vomiting, including gastroparesis (particularly diabetic gastroparesis, which shares overlapping pathophysiology and symptoms with functional dyspepsia), anorexia nervosa, bulimia nervosa, rumination syndrome, cyclic vomiting syndrome, pancreatitis, and gastric outlet obstruction. The differentials include the following:[23][24][25][26]_SpringerLink-27|[27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43]_ScienceDirect_Topics-44|[44][45][46][47][48][49][50][51][52][53][54]
| Disorder | Clinical features | Laboratory findings | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic nausea | Vomiting | Diarrhea | Retching | Lethargy | Social withdrawal | Photophobia | Epigastric pain/burning | Lanugo hair | Hypogonadism | Russel's sign | Body mass index (normal range: 18.5 to 24.9) | Complete blood count (CBC) | Electrolyte imabalance | Lipase and amylase levels | Gastric scintigraphy | Ambulatory esophageal pH and impedance testing | |
| Gastroparesis | ✔ | ✔ (within 1 hour of eating) | - | ✔ | ✔ | - | - | ✔ | - | - | - | ↓ | ✔ |
|
|
| |
| Anorexia nervosa | ✔ | ✔ | ✔ | - | ✔ | ✔ | - | - | ✔ | ✔ | - | ↓ | ✔ |
|
|
| |
| Bulimia nervosa | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | - | - | - | ✔ | ✔ | Normal | ✔ |
|
|
| |
| Rumination syndrome | ✔ | ✔ (Regurgitation more common- within minutes of meal intake) | ✔ | - | ✔ | ✔ | ✔ | ✔ | - | - | - | ↓ |
|
✔ |
|
| |
| Functional dyspepsia | ✔ | ✔ | ✔ | ✔ | - | - | - | - | - | - | - | Normal |
|
✔ |
|
|
|
| Cyclic vomiting syndrome | ✔ | ✔ | - | ✔ | ✔ | - | - | - | - | - | - | ↓ | ✔ |
|
|
| |
| Pancreatitis | ✔ | ✔ | ✔ | ✔ | ✔ | - | - | ✔ | - | - | - | Normal | ✔ |
|
|
| |
| Gastric outlet obstruction | ✔ | ✔ (within 1 hour of eating) | - | - | - | - | - | ✔ | - | - | - | ↓ | ✔ |
|
| ||
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N (2017). "ACG and CAG Clinical Guideline: Management of Dyspepsia". Am J Gastroenterol. 112 (7): 988–1013. doi:10.1038/ajg.2017.154. PMID 28631728.
- ↑ 2.0 2.1 2.2 Black CJ, Paine PA, Agrawal A, Aziz I, Eugenicos MP, Houghton LA, Hungin P, Overshott R, Vasant DH, Rudd S, Winning RC, Corsetti M, Ford AC (2022). "British Society of Gastroenterology guidelines on the management of functional dyspepsia". Gut. 71 (9): 1697–1723. doi:10.1136/gutjnl-2022-327737. PMID 35798375 Check
|pmid=value (help). - ↑ 3.0 3.1 Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ (2016). "Gastroduodenal Disorders". Gastroenterology. 150 (6): 1380–1392. doi:10.1053/j.gastro.2016.02.011. PMID 27147122.
- ↑ 4.0 4.1 Gralnek IM, Barkun AN, Bardou M (2008). "Management of acute bleeding from a peptic ulcer". N Engl J Med. 359 (9): 928–37. doi:10.1056/NEJMra0706113. PMID 18753649.
- ↑ 5.0 5.1 Dallal HJ, Palmer KR (2001). "ABC of the upper gastrointestinal tract: Upper gastrointestinal haemorrhage". BMJ. 323 (7321): 1115–7. PMC 1121602. PMID 11701581.
- ↑ Nelson DR, Teckman J, Di Bisceglie AM, Brenner DA (2012). "Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency". Clin Gastroenterol Hepatol. 10 (6): 575–80. doi:10.1016/j.cgh.2011.12.028. PMC 3360829. PMID 22200689.
- ↑ Tsochatzis EA, Bosch J, Burroughs AK (2014). "Liver cirrhosis". Lancet. 383 (9930): 1749–61. doi:10.1016/S0140-6736(14)60121-5. PMID 24480518.
- ↑ Schuppan D, Afdhal NH (2008). "Liver cirrhosis". Lancet. 371 (9615): 838–51. doi:10.1016/S0140-6736(08)60383-9. PMC 2271178. PMID 18328931.
- ↑ Kahrilas PJ (2008). "Clinical practice. Gastroesophageal reflux disease". N Engl J Med. 359 (16): 1700–7. doi:10.1056/NEJMcp0804684. PMC 3058591. PMID 18923172.
- ↑ Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM; et al. (2008). "American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease". Gastroenterology. 135 (4): 1383–1391, 1391.e1–5. doi:10.1053/j.gastro.2008.08.045. PMID 18789939.
- ↑ Bredenoord AJ, Pandolfino JE, Smout AJ (2013). "Gastro-oesophageal reflux disease". Lancet. 381 (9881): 1933–42. doi:10.1016/S0140-6736(12)62171-0. PMID 23477993.
- ↑ Fox M, Forgacs I (2006). "Gastro-oesophageal reflux disease". BMJ. 332 (7533): 88–93. doi:10.1136/bmj.332.7533.88. PMC 1326932. PMID 16410582.
- ↑ Sugimachi K, Inokuchi K, Kuwano H, Ooiwa T (1984). "Acute gastritis clinically classified in accordance with data from both upper GI series and endoscopy". Scand J Gastroenterol. 19 (1): 31–7. PMID 6710074.
- ↑ Sipponen P, Maaroos HI (2015). "Chronic gastritis". Scand J Gastroenterol. 50 (6): 657–67. doi:10.3109/00365521.2015.1019918. PMC 4673514. PMID 25901896.
- ↑ Sartor RB (2006). "Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis". Nat Clin Pract Gastroenterol Hepatol. 3 (7): 390–407. doi:10.1038/ncpgasthep0528. PMID 16819502.
- ↑ Sipponen P (1989). "Atrophic gastritis as a premalignant condition". Ann Med. 21 (4): 287–90. PMID 2789799.
- ↑ Badillo R, Francis D (2014). "Diagnosis and treatment of gastroesophageal reflux disease". World J Gastrointest Pharmacol Ther. 5 (3): 105–12. doi:10.4292/wjgpt.v5.i3.105. PMC 4133436. PMID 25133039.
- ↑ Ramakrishnan K, Salinas RC (2007). "Peptic ulcer disease". Am Fam Physician. 76 (7): 1005–12. PMID 17956071.
- ↑ Banasch M, Schmitz F (2007). "Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors". Wien Klin Wochenschr. 119 (19–20): 573–8. doi:10.1007/s00508-007-0884-2. PMID 17985090.
- ↑ Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM (2005). "Gastric adenocarcinoma: review and considerations for future directions". Ann Surg. 241 (1): 27–39. PMC 1356843. PMID 15621988.
- ↑ Ghimire P, Wu GY, Zhu L (2011). "Primary gastrointestinal lymphoma". World J Gastroenterol. 17 (6): 697–707. doi:10.3748/wjg.v17.i6.697. PMC 3042647. PMID 21390139.
- ↑ Talley NJ, Ford AC (2015). "Functional Dyspepsia". N Engl J Med. 373 (19): 1853–1863. doi:10.1056/NEJMra1501505. PMID 26535514.
- ↑ Parkman HP (2015). "Idiopathic gastroparesis". Gastroenterol. Clin. North Am. 44 (1): 59–68. doi:10.1016/j.gtc.2014.11.015. PMC 4324534. PMID 25667023.
- ↑ Werlin SL, Fish DL (2006). "The spectrum of valproic acid-associated pancreatitis". Pediatrics. 118 (4): 1660–3. doi:10.1542/peds.2006-1182. PMID 17015559.
- ↑ Noddin L, Callahan M, Lacy BE (2005). "Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations?". MedGenMed. 7 (3): 17. PMC 1681633. PMID 16369243.
- ↑ Gupta R, Kalla M, Gupta JB (2012). "Adult rumination syndrome: Differentiation from psychogenic intractable vomiting". Indian J Psychiatry. 54 (3): 283–5. doi:10.4103/0019-5545.102434. PMC 3512372. PMID 23226859.
- _SpringerLink_27-0|↑ "Body weight in bulimia nervosa | SpringerLink".
- ↑ Sağlam F, Sivrikoz E, Alemdar A, Kamalı S, Arslan U, Güven H (2015). "Bouveret syndrome: A fatal diagnostic dilemma of gastric outlet obstruction". Ulus Travma Acil Cerrahi Derg. 21 (2): 157–9. PMID 25904280.
- ↑ Talley NJ (2011). "Rumination syndrome". Gastroenterol Hepatol (N Y). 7 (2): 117–8. PMC 3061016. PMID 21475419.
- ↑ Tutuian R, Castell DO (2004). "Rumination documented by using combined multichannel intraluminal impedance and manometry". Clin. Gastroenterol. Hepatol. 2 (4): 340–3. PMID 15067630.
- ↑ Kessing BF, Smout AJ, Bredenoord AJ (2014). "Current diagnosis and management of the rumination syndrome". J. Clin. Gastroenterol. 48 (6): 478–83. doi:10.1097/MCG.0000000000000142. PMID 24921208.
- ↑ Parkman HP (2009). "Assessment of gastric emptying and small-bowel motility: scintigraphy, breath tests, manometry, and SmartPill". Gastrointest. Endosc. Clin. N. Am. 19 (1): 49–55, vi. doi:10.1016/j.giec.2008.12.003. PMID 19232280.
- ↑ Waseem S, Moshiree B, Draganov PV (2009). "Gastroparesis: current diagnostic challenges and management considerations". World J. Gastroenterol. 15 (1): 25–37. PMC 2653292. PMID 19115465.
- ↑ Mearin F, Camilleri M, Malagelada JR (1986). "Pyloric dysfunction in diabetics with recurrent nausea and vomiting". Gastroenterology. 90 (6): 1919–25. PMID 3699409.
- ↑ Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ, Ziessman HA (2008). "Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine". Am. J. Gastroenterol. 103 (3): 753–63. doi:10.1111/j.1572-0241.2007.01636.x. PMID 18028513.
- ↑ Jiang CF, Ng KW, Tan SW, Wu CS, Chen HC, Liang CT, Chen YH (2002). "Serum level of amylase and lipase in various stages of chronic renal insufficiency". Zhonghua Yi Xue Za Zhi (Taipei). 65 (2): 49–54. PMID 12014357.
- ↑ Szmukler, G. I.; Young, G. P.; Lichtenstein, M.; Andrews, J. T. (1990). "A serial study of gastric emptying in anorexia nervosa and bulimia". Australian and New Zealand Journal of Medicine. 20 (3): 220–225. doi:10.1111/j.1445-5994.1990.tb01023.x. ISSN 0004-8291.
- ↑ Diamanti A, Bracci F, Gambarara M, Ciofetta GC, Sabbi T, Ponticelli A, Montecchi F, Marinucci S, Bianco G, Castro M (2003). "Gastric electric activity assessed by electrogastrography and gastric emptying scintigraphy in adolescents with eating disorders". J. Pediatr. Gastroenterol. Nutr. 37 (1): 35–41. PMID 12827003.
- ↑ Ferholt J, Provence S (1976). "Diagnosis and treatment of an infant with psychophysiological vomiting". Psychoanal Study Child. 31: 439–59. PMID 981449.
- ↑ Lee H, Rhee PL, Park EH, Kim JH, Son HJ, Kim JJ, Rhee JC (2007). "Clinical outcome of rumination syndrome in adults without psychiatric illness: a prospective study". J. Gastroenterol. Hepatol. 22 (11): 1741–7. doi:10.1111/j.1440-1746.2006.04617.x. PMID 17914944.
- ↑ Koskenpato J, Kairemo K, Korppi-Tommola T, Färkkilä M (1998). "Role of gastric emptying in functional dyspepsia: a scintigraphic study of 94 subjects". Dig. Dis. Sci. 43 (6): 1154–8. PMID 9635600.
- ↑ Urbain JL, Vekemans MC, Parkman H, Van Cauteren J, Mayeur SM, Van den Maegdenbergh V, Charkes ND, Fisher RS, Malmud LS, De Roo M (1995). "Dynamic antral scintigraphy to characterize gastric antral motility in functional dyspepsia". J. Nucl. Med. 36 (9): 1579–86. PMID 7658213.
- ↑ Hejazi RA, Lavenbarg TH, McCallum RW (2010). "Spectrum of gastric emptying patterns in adult patients with cyclic vomiting syndrome". Neurogastroenterol. Motil. 22 (12): 1298–302, e338. doi:10.1111/j.1365-2982.2010.01584.x. PMID 20723071.
- _ScienceDirect_Topics_44-0|↑ "Gastric outlet obstruction - an overview | ScienceDirect Topics".
- ↑ Minami H, McCallum RW (1984). "The physiology and pathophysiology of gastric emptying in humans". Gastroenterology. 86 (6): 1592–610. PMID 6370777.
- ↑ Humphries LL, Adams LJ, Eckfeldt JH, Levitt MD, McClain CJ (1987). "Hyperamylasemia in patients with eating disorders". Ann. Intern. Med. 106 (1): 50–2. PMID 2431640.
- ↑ Hempen I, Lehnert P, Fichter M, Teufel J (1989). "[Hyperamylasemia in anorexia nervosa and bulimia nervosa. Indication of a pancreatic disease?]". Dtsch. Med. Wochenschr. (in German). 114 (49): 1913–6. doi:10.1055/s-2008-1066848. PMID 2480214.
- ↑ Okada R, Okada A, Okada T, Okada T, Hamajima N (2009). "Elevated serum lipase levels in patients with dyspepsia of unknown cause in general practice". Med Princ Pract. 18 (2): 130–6. doi:10.1159/000189811. PMID 19204432.
- ↑ Sansone RA, Sansone LA (2012). "Hoarseness: a sign of self-induced vomiting?". Innov Clin Neurosci. 9 (10): 37–41. PMC 3508961. PMID 23198276.
- ↑ Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J (2005). "Prevalence of acid reflux in functional dyspepsia and its association with symptom profile". Gut. 54 (10): 1370–6. doi:10.1136/gut.2004.053355. PMC 1774686. PMID 15972301.
- ↑ "gut.bmj.com" (PDF).
- ↑ Boles RG, Williams JC (1999). "Mitochondrial disease and cyclic vomiting syndrome". Dig. Dis. Sci. 44 (8 Suppl): 103S–107S. PMID 10490048.
- ↑ Ranasinghe WK, Smith M (2013). "Gastric outlet obstruction with an elevated serum pancreatic lipase secondary to an infraumbilical hernia". Ann R Coll Surg Engl. 95 (7): 122–4. doi:10.1308/003588413X13629960047795. PMID 24112485.
- ↑ Ui, Takashi; Shibusawa, Hiroyuki; Tsukui, Hidenori; Sakuma, Kazuya; Takahashi, Shuhei; Lefor, Alan K.; Hosoya, Yoshinori; Sata, Naohiro; Yasuda, Yoshikazu (2015). "Pretreatment of gastric outlet obstruction with pancrelipase: Report of a case". International Journal of Surgery Case Reports. 12: 87–89. doi:10.1016/j.ijscr.2015.05.023. ISSN 2210-2612.